Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.20 +0.04 (+3.45%)
As of 07/1/2025

DHAC vs. BRTX, MGRX, SSY, BGLC, ACON, OTRK, VSEE, ATIP, NIVF, and BACK

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Ontrak (OTRK), VSee Health (VSEE), ATI Physical Therapy (ATIP), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

Biorestorative Therapies (NASDAQ:BRTX) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Digital Health Acquisition has lower revenue, but higher earnings than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biorestorative Therapies$400K29.70-$8.98M-$1.47-1.08
Digital Health AcquisitionN/AN/AN/AN/AN/A

Biorestorative Therapies has a beta of 75.28, meaning that its share price is 7,428% more volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500.

Biorestorative Therapies presently has a consensus target price of $18.00, indicating a potential upside of 1,036.36%. Given Biorestorative Therapies' stronger consensus rating and higher probable upside, analysts plainly believe Biorestorative Therapies is more favorable than Digital Health Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

69.4% of Biorestorative Therapies shares are owned by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are owned by institutional investors. 25.5% of Biorestorative Therapies shares are owned by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Digital Health Acquisition has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. Digital Health Acquisition's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biorestorative Therapies-3,093.61% -129.47% -86.02%
Digital Health Acquisition N/A N/A N/A

In the previous week, Biorestorative Therapies had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for Biorestorative Therapies and 0 mentions for Digital Health Acquisition. Biorestorative Therapies' average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Biorestorative Therapies Neutral
Digital Health Acquisition Neutral

Summary

Biorestorative Therapies beats Digital Health Acquisition on 8 of the 11 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$4.33M$177.52M$487.89M$9.05B
Dividend YieldN/A5.41%N/A4.02%
P/E RatioN/A2.48N/A20.22
Price / SalesN/A435.632.75118.64
Price / CashN/A74.78N/A58.07
Price / BookN/A6.473.655.67
Net IncomeN/A$3.67M-$2.48M$249.13M
7 Day Performance9.09%0.61%8.69%3.28%
1 Month Performance-4.76%1.46%23.81%5.56%
1 Year Performance-88.57%75.40%106.36%21.12%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.20
+3.4%
N/A-88.6%$4.33MN/A0.002,021Gap Up
BRTX
Biorestorative Therapies
2.7696 of 5 stars
$1.67
+0.9%
$18.00
+981.1%
-15.3%$12.50M$400K-1.137
MGRX
Mangoceuticals
0.8611 of 5 stars
$1.78
-2.7%
N/A-97.8%$9.20M$620K-0.383News Coverage
SSY
SunLink Health Systems
N/A$0.87
-4.0%
N/A+16.6%$6.09M$31.09M6.181,376Positive News
BGLC
BioNexus Gene Lab
0.4326 of 5 stars
$2.70
+2.9%
N/A+33.5%$4.85M$9.51M0.0030Gap Down
ACON
Aclarion
2.5084 of 5 stars
$7.16
+1.1%
$11,758.50
+164,239.6%
-99.7%$4.14M$50K0.007News Coverage
OTRK
Ontrak
2.9011 of 5 stars
$0.97
-1.0%
$45.00
+4,563.2%
-83.8%$4.07M$10.85M-0.06250News Coverage
VSEE
VSee Health
1.2371 of 5 stars
$1.13
+6.6%
$5.00
+342.5%
N/A$4.07MN/A0.00N/A
ATIP
ATI Physical Therapy
0.1968 of 5 stars
$0.86
-2.3%
N/A-80.8%$3.79M$741.86M-0.055,600Gap Down
NIVF
NewGenIvf Group
N/A$1.12
+7.2%
N/A-99.5%$586K$5.43M0.00N/APositive News
Gap Up
High Trading Volume
BACK
IMAC
N/A$0.05
+16.5%
N/A-97.0%$104K$72.05K0.00180Gap Up

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners